For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Atossa Genetics Inc. (ATOS) one of those stocks right now? By ...

Atossa Genetics Inc. (ATOS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) is anticipated to release its earnings data before the market opens on Monday, April 7th. Analysts expect Atossa Therapeutics to post earnings of ...

The MarketWatch News Department was not involved in the creation of this content. Company reports progress to file planned IND for (Z)-endoxifen in mBC with CRO selection and streamlined development ...

SEATTLE, March 25, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, ...

Good morning, everyone, and welcome to the Atossa Therapeutics Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is Joelle, and I will be your conference operator today. All ...

Detailed price information for Atossa Therapeutics Inc (ATOS-Q) from The Globe and Mail including charting and trades.

Detailed price information for Atossa Therapeutics Inc (ATOS-Q) from The Globe and Mail including charting and trades.

The MarketWatch News Department was not involved in the creation of this content. Company positioned to pursue expedited regulatory pathways in metastatic, neoadjuvant, and risk-reduction settings ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Atossa Genetics Inc. (ATOS) one of those stocks right now? Let ...